NASDAQ · Analyst Forecast

Beta Bionics, Inc. (BBNX) Stock Forecast & Price Target

$14.72 NASDAQ: BBNX Market Cap $662.25M

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 16, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Beta Bionics, Inc. (BBNX), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Beta Bionics, Inc., analysts forecast revenue rising from $98.58M in 2025 to $478.77M in 2030; the average estimate for 2030 earnings per share is −$0.64; with published estimates ranging from −$0.70 to −$0.60; 11 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$14.72
Consensus targetThe average of the price targets analysts have published.$24.09
Median targetThe middle target, less affected by a single outlier.$24.00
Highest targetThe most optimistic published target.$30.00
Lowest targetThe most pessimistic published target.$16.00
Difference from priceHow far the consensus target sits from today’s price.+63.7%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$97.36M$98.58M$100.99M8
2026$125.13M$125.54M$125.84M10
2027$176.24M$184.65M$189.06M10
2028$265.51M$284.54M$338.73M11
2029$352.11M$369.98M$394.86M5
2030$455.65M$478.77M$510.97M5

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$2.02−$1.97−$1.888
2026−$2.08−$2.04−$1.9810
2027−$2.78−$2.13−$1.7810
2028−$2.75−$1.59−$1.1311
2029−$1.56−$1.43−$1.345
2030−$0.70−$0.64−$0.605

Beta Bionics, Inc. (BBNX) forecast — frequently asked questions

What is the analyst price target for Beta Bionics, Inc.?

Analysts covering Beta Bionics, Inc. (BBNX) have a consensus price target of $24.09, 63.7% above the current price of $14.72. Published targets range from $16.00 to $30.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Beta Bionics, Inc.'s earnings?

The average analyst estimate for Beta Bionics, Inc. (BBNX) earnings per share in 2030 is -0.64, with individual estimates between -0.70 and -0.60.

How much revenue is Beta Bionics, Inc. expected to make?

Analysts forecast Beta Bionics, Inc. (BBNX) revenue of $478.77M in 2030, based on 5 published estimates.

How many analysts cover BBNX?

11 analysts contribute estimates for Beta Bionics, Inc. (BBNX). Thin coverage makes an average less reliable.

Analyst forecasts for other Medical - Equipment & Services stocks

CON forecastMMED forecastLLY forecastJNJ forecastABBV forecastMRK forecastUNH forecastNVS forecastAZN forecastTMO forecastAll Medical - Equipment & Services stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.